Quality of Life in Multiple Myeloma Patients Treated With Bortezomib

CompletedOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Multiple Myeloma

Interventions

DRUG

bortezomib

Injection into a vein 1.3 mg/m2 twice a week for 21 days

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01021592 - Quality of Life in Multiple Myeloma Patients Treated With Bortezomib | Biotech Hunter | Biotech Hunter